Reuters logo
BRIEF-Trillium provides update on small molecule programs
July 5, 2017 / 11:20 AM / 5 months ago

BRIEF-Trillium provides update on small molecule programs

July 5 (Reuters) - Trillium Therapeutics Inc

* Trillium provides update on small molecule programs

* Trillium says concluded that TTI-2341 appears to be a viable and competitive drug candidate for treatment of brain cancers and brain metastases

* Trillium Therapeutics Inc says plans to continue to pursue internal development of TTI-2341 while undertaking partnering discussions in parallel

* Trillium Therapeutics Inc says has launched a discovery program that is focused on an undisclosed early-stage immuno-oncology target Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below